EllulMABenjaminLSinghB, et al. Neurological associations of COVID-19. Lancet Neurol2020; 19(9): 767–783.
2.
CorrêaDGSouza LimaFda Cruz BezerraD, et al. COVID-19 associated with encephalomyeloradiculitis and positive anti-aquaporin-4 antibodies: Cause or coincidence?Mult Scler2021; 27(6): 973–976.
3.
ArmangueTSpatolaMVlageaA, et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: A prospective observational study and retrospective analysis. Lancet Neurol2018; 17(9): 760–772.
4.
MachadoCAmorimJRochaJ, et al. Neuromyelitis optica spectrum disorder and varicella-zoster infectionJ Neurol Sci2015; 358(1–2): 520–521.
5.
BizzocoELolliFRepiceAM, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol2009; 256(11): 1891–1898.
6.
SellnerJHemmerBMühlauM.The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J Autoimmun2010; 34(4): 371–379.
7.
UzawaAMoriMAraiK, et al. Cytokine and chemokine profiles in neuromyelitis optica: Significance of interleukin-6. Mult Scler2010; 16(12): 1443–1452.
8.
LiuFLiLXuM, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol2020; 127: 104370.
